Sign in

    John Granville Pinney • Canaccord Genuity Group Inc.

    John Granville Pinney is an Analyst at Canaccord Genuity Group Inc., specializing in health care services and health technology equity research. He covers companies including Clover Health Investments, Adapthealth Corp, and Accolade Inc., contributing to detailed earnings analyses and industry insights, though specific performance metrics and rankings have not been published. Pinney has over five years of experience in the finance industry and has previously worked at at least one other firm before joining Canaccord Genuity. He holds FINRA registration and is licensed to operate in two states, reflecting his professional credentials and regulatory compliance.

    John Granville Pinney's questions to Health Catalyst Inc (HCAT) leadership

    John Granville Pinney's questions to Health Catalyst Inc (HCAT) leadership • Q4 2024

    Question

    John Pinney, on for Richard Close, asked about the M&A environment in 2025, including valuation trends and whether Health Catalyst is open to further acquisitions.

    Answer

    CEO Dan Burton stated that the company's primary focus for 2025 is on integrating its four recent acquisitions and generating a strong return on those investments. He noted that while they will continue to monitor the market, it is less likely they will pursue other acquisitions in the near-to-midterm. He highlighted that early progress on integration efforts enabled them to raise the full-year 2025 adjusted EBITDA forecast.

    Ask Fintool Equity Research AI